PUBLIC CONTRACT · 2020

201G000971 - Aquisição de FACTOR VIII RECOMBINANTE INJ (OCTOCOG ALFA 3aGERAÇAO-ADVATE) -Ano 2020

Contract value: €348,964.00
Signed on: 26 May 2020
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 6629682

PUBLISHED SUBJECT

WHO CONTRACTED

Parties involved

Contracting body: Centro Hospitalar Universitário de Lisboa Norte, E. P. E.
Awardee: TAKEDA - FARMACEUTICA PORTUGAL, LDA (ANTIGA NYCOMED)
Place of performance: Portugal, Lisboa, Lisboa
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: TAKEDA - FARMACEUTICA PORTUGAL, LDA (ANTIGA NYCOMED) · Tax ID 502801204
Bidder: SHIRE PHARMACEUTICALS PORTUGAL, LDA · Tax ID 509264662

HOW MUCH AND WHEN

Values and timeline

Contract price: €348,964.00
Procedure base price: €348,964.00
Total effective price: Not reported on Portal BASE
Publication date: 27 May 2020
Award date: 16 April 2020
Signing date: 26 May 2020
Performance period: 219 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Preço ou custo
CPV code: 33690000-3 - Medicamentos vários
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 4473694

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts